{"text": "RT @syinvesting: Goldman views #oncology as a top #biopharma M&amp;A focus in 2020.\n\nHere's an interesting look at historical oncology deals an\u2026", "author_id": "1136370591517290496", "id": "1214285243861127168", "created_at": "2020-01-06T20:38:57.000Z"}
{"text": "RT @AndyBiotech: #Biotech Key Data Expected in Early 2020\n\n$LLY Solanezumab DIAN-TU\n$APLS Ph3 PNH\n$ACST Ph3 TRILOGY\n$APLT Galactosemia\n$BHV\u2026", "author_id": "329722982", "id": "1214327868555063301", "created_at": "2020-01-06T23:28:19.000Z"}
{"text": "RT @syinvesting: The KRAS focus of the $MRK/Taiho/Astex deal adds more players to an already competitive space.\n\nThe leading clinical-stage\u2026", "author_id": "3295314779", "id": "1214243689842827268", "created_at": "2020-01-06T17:53:49.000Z"}
